Issue 6/2003
Content (8 Articles)
Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists?
Stefan Walenta, The-Van Chau, Thies Schroeder, Hans-Anton Lehr, Leoni A. Kunz-Schughart, Alois Fuerst, Wolfgang Mueller-Klieser
Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts
Wei-Dong Jia, Ge-Liang Xu, Rong-Nan Xu, Hui-Chuan Sun, Lu Wang, Ji-Hai Yu, Jian Wang, Jian-Sheng Li, Zhi-Ming Zhai, Qiong Xue
High susceptibility of nullizygous p53 knockout mice to colorectal tumor induction by 1,2-dimethylhydrazine
Hiroki Sakai, Tetsuya Tsukamoto, Masami Yamamoto, Norimitsu Shirai, Takeshi Iidaka, Akihiro Hirata, Tokuma Yanai, Toshiaki Masegi, Lawrence A. Donehower, Masae Tatematsu
Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cells
Wei Xiang, Pauline Wimberger, Torsten Dreier, Joachim Diebold, Doris Mayr, Patrick A. Baeuerle, Rainer Kimmig
Analysis of DLC-1 expression in human breast cancer
Marlies Plaumann, Susanne Seitz, Renate Frege, Lope Estevez-Schwarz, Siegfried Scherneck
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma
Masahiro Munaka, Kiyotaka Kohshi, Toshihiro Kawamoto, Shin Takasawa, Naoki Nagata, Hideaki Itoh, Susumu Oda, Takahiko Katoh
Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer
Herbert G. Sayer, Kristina Schilling, Tobias Vogt, Kerstin Blumenstengel, Miriam Charbel Issa, Lars-Olof Mügge, Christoph Kasper, Roland Kath, Klaus Höffken
Adenovirus-mediated prodrug-enzyme therapy for CEA-producing colorectal cancer cells
Satoshi Okabe, Takehiro Arai, Hironori Yamashita, Kenichi Sugihara